Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: Insights from the cardiac arrhythmia suppression trial (CAST)

Clinical Cardiology

Volumn 23, Issue 3, 2000, Pages 187-194

  Stein, Phyllis K ^a,b   Domitrovich, Peter P ^b   Kleiger, Robert E ^a   Schechtman, Kenneth B ^a   Rottman, Jeffrey N ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery bypass graft surgery (CABG); Diabetes; Heart rate variability; Postmyocardial infarction

Indexed keywords

ENCAINIDE; FLECAINIDE; MORACIZINE;

ARTICLE; CALIBRATION; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION;

EID: 0034092609     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230311     Document Type: Article

References (14)

1. Kleiger RE, Miller JP, Bigger JT: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256
2. Stein PK, Kleiger RE: Insights from the study of heart rate variability. Ann Rev Med 1999;50:249-261
3. Epstein AE, Bigger JT Jr, Wyse DG: Events in the Cardiac Arrhythmia Suppression Trial (CAST): Mortality in the entire population enrolled. J Am Coll Cardiol 1991;18:14-19
4. Hallstrom Al, Pratt CM, Greene HL: Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: Analysis of the Cardiac Arrhythmia Suppression Trial. J Am Coll Cardiol 1005;25:1250-1257
5. Echt DS, Liebson PR, Mitchell LF: Mortality and morbidity in patients receiving encainide, flecainide or placebo. N Engl J Med 1991;324:781-788
6. The Cardiac Arrhythmia Suppression Trial II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233
7. Berger, RD, Akselrod S, Gordon D: An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng 1986;9:900-904
8. Rottman JN, Steinman RC, Albrecht P: Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. Am J Cardiol 1990;66:1522-1524
9. Kleiger RE, Stein PK, Bosner MS: Time domain measurements of heart rate variability. Cardiol Clin N Am 1992;10:478-487
10. Bigger JT, Fleiss JL, Steinman RC: Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992;69:891-898
11. Hogue CW, Stein PK, Apostolidou I: Alterations in temporal patterns of heart rate variability after coronary bypass surgery. Anaesthesiology 1994;81:1356-1364
12. Niemela MJ, Airaksinen KE, Tahvanainen KU: Effect of coronary artery bypass grafting on cardiac parasympathetic nervous function. Eur Heart J 1992;13:932-935
13. Piha S, Hämäläinen H: Effect of coronary bypass grafting on autonomie cardiovascular reflexes. Ann Med 1994;26:53-56
14. Bigger JT, Fleiss LF, Steinman RC: RR variability in healthy, middle-age persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995;91:1936-1943